News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Up as Novartis Corporation (NVS) Drops Generic Advair in U.S.; Novartis Hands Back U.S. Rights to VR315 to Vectura Limited



3/18/2010 7:03:21 AM

Reuters -- Novartis has handed back U.S. rights to a drug widely believed to be a generic version of GlaxoSmithKline's lung blockbuster Advair, reducing the risk of cheap copies in Glaxo's biggest market.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES